Humanin Side Effects

Known side effects

The following side effects have been reported in research studies and user reports for Humanin:

• Very limited human safety data
• Potential interaction with IGF-1 signaling pathways
• Unknown long-term effects
• No standardized pharmaceutical formulation exists

Severity and frequency

Limited clinical data is available for Humanin. Side effect frequency and severity are based on available research and anecdotal reports. More data is needed for definitive safety profiles.

When to seek medical attention

Contact your healthcare provider immediately if you experience:

• Severe or persistent symptoms that do not improve
• Signs of an allergic reaction (rash, swelling, difficulty breathing)
• Severe abdominal pain
• Changes in vision or neurological symptoms
• Any symptom that concerns you

Risk factors

Side effect risk may be higher in certain populations. Discuss your complete medical history with your doctor, including:

• Pre-existing medical conditions
• Current medications (drug interactions)
• Pregnancy or plans to become pregnant
• History of allergic reactions to peptides or similar compounds
• Note: Humanin is a research compound without established human safety data from FDA-approved clinical trials

Research references

• Humanin, a newly identified neuroprotective factor — Journal of Biological Chemistry (2001) [PubMed]
• The mitochondrial-derived peptide humanin activates the ERK1/2, AKT, and STAT3 signaling pathways — Journal of Biological Chemistry (2009) [PubMed]
• Humanin and age-related diseases: a new link? — Frontiers in Endocrinology (2018) [PubMed]
• Mitochondrial-derived peptide humanin improves insulin sensitivity — American Journal of Physiology (2014) [PubMed]
• Circulating levels of humanin in centenarians — Aging Cell (2020) [PubMed]
• Humanin prevents age-related cognitive decline in mice and is associated with improved cognitive age in humans — Scientific Reports (2018) [PubMed]